Lichen International Limited
LICN
$3.53
$0.3711.71%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 41.93M | 40.84M | 39.76M | 36.67M | 33.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.93M | 40.84M | 39.76M | 36.67M | 33.58M |
| Cost of Revenue | 16.47M | 15.96M | 15.44M | 14.70M | 13.97M |
| Gross Profit | 25.46M | 24.89M | 24.32M | 21.97M | 19.62M |
| SG&A Expenses | 14.35M | 13.20M | 12.06M | 11.97M | 11.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.82M | 29.16M | 27.50M | 26.68M | 25.85M |
| Operating Income | 11.11M | 11.68M | 12.26M | 10.00M | 7.73M |
| Income Before Tax | 11.20M | 11.40M | 11.59M | 9.27M | 6.95M |
| Income Tax Expenses | 3.45M | 3.35M | 3.25M | 2.68M | 2.11M |
| Earnings from Continuing Operations | 7.75 | 8.04 | 8.34 | 6.59 | 4.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.75M | 8.04M | 8.34M | 6.59M | 4.84M |
| EBIT | 11.11M | 11.68M | 12.26M | 10.00M | 7.73M |
| EBITDA | 11.75M | 12.38M | 13.01M | 10.89M | 8.76M |
| EPS Basic | 57.83 | 60.55 | 63.26 | 52.42 | 41.58 |
| Normalized Basic EPS | 51.92 | 53.46 | 54.99 | 46.07 | 37.15 |
| EPS Diluted | 57.83 | 60.55 | 63.26 | 52.42 | 41.58 |
| Normalized Diluted EPS | 51.92 | 53.46 | 54.99 | 46.07 | 37.15 |
| Average Basic Shares Outstanding | 562.40K | 541.90K | 521.40K | 501.40K | 481.40K |
| Average Diluted Shares Outstanding | 562.40K | 541.90K | 521.40K | 501.40K | 481.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |